# A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines

> **NCT01949675** · PHASE4 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 336 (actual)

## Conditions studied

- Cholera

## Interventions

- **BIOLOGICAL:** Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell
- **BIOLOGICAL:** Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell
- **BIOLOGICAL:** Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell

## Key facts

- **NCT ID:** NCT01949675
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-02
- **Final completion:** 2015-08
- **Target enrollment:** 336 (ACTUAL)
- **Last updated:** 2018-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01949675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01949675, "A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01949675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*